0 219

Cited 0 times in

Cited 0 times in

Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)

Authors
 E.B. Garon  ;  S. Lu  ;  Y. Goto  ;  P.R. De Marchi  ;  L. Paz-Ares  ;  D.R. Spigel  ;  M. Thomas  ;  J.C-H. Yang  ;  A. Ardizzoni  ;  F. Barlesi  ;  S. Khanna  ;  C. Bossen  ;  M. Carbini  ;  A. Yovine  ;  B.C. Cho 
Citation
 ANNALS OF ONCOLOGY, Vol.33(7) : S1414-S1415, 2022-09 
Journal Title
ANNALS OF ONCOLOGY
ISSN
 0923-7534 
Issue Date
2022-09
Full Text
https://www.sciencedirect.com/science/article/pii/S0923753422039278
DOI
10.1016/j.annonc.2022.08.049
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194379
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links